PulmonX's Series A Round

PulmonX raised a round of funding on January 07, 2004.

PulmonX is engaged in the design, development and manufacture of products to deliver effective endoscopic lung volume reduction (ELVR) to patients with emphysema-induced hyperinflation. ELVR involves …

Articles about PulmonX's Series A Round: